Javier T. Solera
Research areas: Medicine · Infectious Diseases · COVID-19 Clinical Research Studies · SARS-CoV-2 and COVID-19 Research · Transplantation: Methods and Outcomes
0000-0001-6833-6625
About
Javier Tomás Solera Rallo, MD, is an Infectious Diseases physician and transplant infectious diseases specialist at University of Miami Miller School of Medicine, with clinical practice at the Miami Transplant Institute / Jackson Memorial Hospital. His work focuses on infections in solid organ transplant recipients and other immunocompromised hosts, with particular expertise in viral infections (CMV, BK virus, respiratory viruses), immunologic monitoring, and optimization of antimicrobial strategies.
He earned his medical degree from University of Castilla-La Mancha (Spain) and completed residency training in Internal Medicine at Hospital Universitario 12 de Octubre (Madrid, Spain). He further specialized through a clinical fellowship in Transplant and Oncohematology Infectious Diseases at University Health Network – Ajmera Transplant Centre (Toronto, Canada), where he served as Transplant Chief Fellow and junior attending.
From 2023 to 2025, he served as Infectious Diseases attending physician and Antimicrobial Stewardship Program Coordinator at Hospital Universitario Quirónsalud Madrid, where he led antimicrobial stewardship initiatives and contributed to the development of institutional clinical guidelines. He has held academic appointments at Complutense University of Madrid and as Associate Professor at Universidad Europea (2023–2025).
Dr. Solera has formal training in biostatistics and research methods from Autonomous University of Barcelona and maintains an active research portfolio in transplant infectious diseases and cardiovascular infections. He has contributed to multicenter cohort studies and clinical research on infective endocarditis and opportunistic infections in immunocompromised patients , with peer-reviewed publications in high-impact journals including The Lancet Infectious Diseases, Clinical Infectious Diseases, American Journal of Transplantation, and Nature Communications.
He serves as a reviewer for multiple international journals and is currently completing a joint international PhD between Complutense University of Madrid and University of Toronto focused on optimizing prevention and treatment strategies for COVID-19 in solid organ transplant recipients.
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (32)
- Baseline Antithrombotic Therapy and Intracranial Hemorrhage Risk in Infective Endocarditis: A Multicenter Prospective Cohort Study Save
- New cases of δ‐aminolevulinic acid dehydratase deficiency: Functional insights into gene variants using an innovative mouse liver model Save
- Cell-mediated Immunity to Guide Primary Prophylaxis for CMV Infection in Organ Transplant Recipients: A Multicenter Single-arm Prospective Study Save
- Influence of anti-Spike protein antibody levels on tocilizumab efficacy in hospitalized patients with severe COVID-19 pneumonia: a post-hoc analysis of the COVACTA trial Save
- SLAMF7 and SLAMF8 receptors shape human plasmacytoid dendritic cell responses to intracellular bacteria Save
- SLAMF7 and SLAMF8 receptors shape human plasmacytoid dendritic cell responses to intracellular bacteria (VOL 135, e198064, 2025) Save
- Severe Outcomes of Pneumocystis Pneumonia: A 10-year Retrospective Cohort Study Save
- Longitudinal outcomes of COVID-19 in solid organ transplant recipients from 2020 to 2023 Save
- Are Solid Organ Transplant Recipients with Pneumocystis Pneumonia at a Greater Risks of Unfavorable Outcomes Compared to Other Immunocompromised Patients? Save
- COVID-19 Reinfection Has Better Outcomes Than the First Infection in Solid Organ Transplant Recipients Save
- Impact of COVID-19 Infection on the Development of Chronic Lung Allograft Dysfunction (CLAD) After Lung Transplantation Save
- SLAMF7 and SLAMF8 receptors shape human plasmacytoid dendritic cell responses to intracellular bacteria Save
- Which immunodeficiency status has greater risks of poor pneumocystic pneumonia outcomes than other immunocompromised populations? Save
- Which immunodeficiency status has greater risks of poor pneumocystic pneumonia outcomes than other immunocompromised populations? Save
- Impact of Omicron BA.1 infection on BA.4/5 immunity in transplant recipients Save
- Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients Save
- Immunogenicity and Safety of Booster SARS-CoV-2 mRNA Vaccine Dose in Allogeneic Hematopoietic Stem Cell Transplantation Recipients Save
- Longitudinal Outcomes of COVID-19 in a Large Cohort of Transplant Recipients 2020-2022 Save
- Mathematical modelling of the waning of anti-RBD IgG SARS-CoV-2 antibody titers after a two-dose BNT162b2 mRNA vaccination Save
- Re-infections with SARS-CoV-2 and Severity in Solid Organ Transplant Recipients: A Matched Case-Control Study Save